Huntington's disease: CAG genetics expands neurobiology

https://doi.org/10.1016/0959-4388(95)80072-7Get rights and content

Abstract

Huntington's disease, with its progressive uncontrolled movements and characteristic selective neuropathology, has represented a baffling enigma to geneticists and neurobiologists alike. Discovery of the HD gene and its defect has demystified the genetic aspects of the disorder, but has not yet explained its pathogenesis. Attempts to explore this issue suggest that the defect acts as a gain of function, conferring a new deleterious property on the huntingtin protein, and that the gene's normal function may be irrelevant to the disease process.

References (56)

  • YP Goldberg et al.

    Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects

    Nature Genet

    (1993)
  • LH Barron et al.

    A study of the Huntington's disease associated trinucleotide repeat in the Scottish population

    J Med Genet

    (1993)
  • D Craufurd et al.

    Mutation size and age at onset in Huntington's disease

    J Med Genet

    (1993)
  • KE De Rooij et al.

    Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range

    J Med Genet

    (1993)
  • C Dode et al.

    Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis

    C R Acad Sci [III]

    (1993)
  • A Norremolle et al.

    Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families

    Hum Mol Genet

    (1993)
  • SA Simpson et al.

    Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease

    J Med Genet

    (1993)
  • OC Stine et al.

    Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15

    Hum Mol Genet

    (1993)
  • C Zuhlke et al.

    Expansion of the (CAG)n repeat causing Huntington's disease in 352 patients of German origin

    Hum Mol Genet

    (1993)
  • E Almqvist et al.

    Geographical distribution of haplotypes in Swedish families with Huntington's disease

    Hum Genet

    (1994)
  • T Ashizawa et al.

    CAG repeat size and clinical presentation in Huntington's disease

    Neurology

    (1994)
  • J Benitez et al.

    Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's disease

    Hum Genet

    (1994)
  • B Kremer et al.

    A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats

    N Engl J Med

    (1994)
  • G Lucotte et al.

    Trinucleotide repeat elongation in the huntingtin gene in Huntington's disease patients from 85 French families

    Genet Couns

    (1994)
  • K Meszaros et al.

    Huntington chorea: (CAG)n repeats on gene IT 15 in Austria

    Wien Klin Wochenschr

    (1994)
  • A Novelletto et al.

    Polymorphism analysis of the huntingtin gene in Italian families affected with Huntington disease

    Hum Mol Genet

    (1994)
  • A Novelletto et al.

    Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease

    Hum Mol Genet

    (1994)
  • Y Trottier et al.

    Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset

    J Med Genet

    (1994)
  • Cited by (54)

    • Principles and Practice of Movement Disorders

      2021, Principles and Practice of Movement Disorders
    • The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models

      2018, Neuroscience
      Citation Excerpt :

      Clinically, HD is characterized by severe motor impairments, namely chorea, bradykinesia, incoordination and rigidity. Post-mortem examinations of HD brains revealed a massive loss of striatal neurons, with up to 95% of GABAergic MSNs (Gusella and MacDonald, 1995; Halliday et al., 1998). At the molecular level, it was proposed that soluble mutant huntingtin protein (mHtt) may be cytotoxic and, thereby, have detrimental effects on several cellular processes, including gene transcription, mitochondrial activity and vesicle trafficking, all features that contribute to the progression of neuronal cell death (Ross and Tabrizi, 2011).

    • Genetics of Neurodegenerative Diseases

      2012, Basic Neurochemistry
    • Genetics of Neurodegenerative Diseases

      2011, Basic Neurochemistry: Principles of Molecular, Cellular, and Medical Neurobiology: Eighth Edition
    • Nonprimary dystonias

      2011, Handbook of Clinical Neurology
      Citation Excerpt :

      Huntington's disease (HD) (Chapters 1–5) is an autosomal-dominant and almost completely penetrant degenerative disorder caused by a CAG triplet repeat on chromosome 4p16.3 of more than 35 (Gusella et al., 1983; MacDonald et al., 1993; Bates, 2005). With increased CAG triplet repeats, the manifestation age decreases (anticipation) and the disease severity increases (The Huntington's Collaborative Research Group, 1993; Gusella and MacDonald, 1995). Although the usual manifestation age is between 30 and 40 years, rare CAG triplet repeats of more than 60 may produce juvenile HD (Walker, 2007).

    View all citing articles on Scopus
    View full text